Global Respiratory Syncytial Virus (RSV) Diagnostics Market Growth (Status and Outlook) 2025-2031

September 2025 | 98 pages | ID: GF1211C4B9CBEN
LP Information

Abstracts

According to this study, the global Respiratory Syncytial Virus (RSV) Diagnostics market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Respiratory Syncytial Virus (RSV) Diagnostics Industry Forecast” looks at past sales and reviews total world Respiratory Syncytial Virus (RSV) Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Respiratory Syncytial Virus (RSV) Diagnostics sales for 2025 through 2031. With Respiratory Syncytial Virus (RSV) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Respiratory Syncytial Virus (RSV) Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Respiratory Syncytial Virus (RSV) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Respiratory Syncytial Virus (RSV) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Respiratory Syncytial Virus (RSV) Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Respiratory Syncytial Virus (RSV) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Respiratory Syncytial Virus (RSV) Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus (RSV) Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Molecular Diagnosis
• Rapid Antigen Testing
• Other

Segmentation by Application:

• Hospital
• Clinic
• Laborary
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• AstraZeneca
• Merck
• AbbVie
• Bausch Health
• GlaxoSmithKline
• ReViral
• Gilead Sciences
• Teva Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size (2020-2031)
  2.1.2 Respiratory Syncytial Virus (RSV) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Respiratory Syncytial Virus (RSV) Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Respiratory Syncytial Virus (RSV) Diagnostics Segment by Type
  2.2.1 Molecular Diagnosis
  2.2.2 Rapid Antigen Testing
  2.2.3 Other
2.3 Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type
  2.3.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Respiratory Syncytial Virus (RSV) Diagnostics Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Laborary
  2.4.4 Other
2.5 Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application
  2.5.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application (2020-2025)

3 RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Player
  3.1.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSTICS BY REGION

4.1 Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2020-2025)
4.2 Global Respiratory Syncytial Virus (RSV) Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth (2020-2025)
4.4 APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth (2020-2025)
4.5 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2020-2025)
5.2 Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025)
5.3 Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2020-2025)
6.2 APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025)
6.3 APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2020-2025)
7.2 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025)
7.3 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RESPIRATORY SYNCYTIAL VIRUS (RSV) DIAGNOSTICS MARKET FORECAST

10.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.1.3 APAC Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.1.4 Europe Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.1.5 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Forecast
10.2 Americas Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.2.2 Canada Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.2.3 Mexico Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.2.4 Brazil Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
10.3 APAC Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Region (2026-2031)
  10.3.1 China Respiratory Syncytial Virus (RSV) Diagnostics Market Forecast
  10.3.2 Japan Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.3.3 Korea Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.3.4 Southeast Asia Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.3.5 India Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.3.6 Australia Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
10.4 Europe Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.4.2 France Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.4.3 UK Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.4.4 Italy Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.4.5 Russia Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
10.5 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.5.2 South Africa Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.5.3 Israel Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
  10.5.4 Turkey Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast
10.6 Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Type (2026-2031)
10.7 Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Respiratory Syncytial Virus (RSV) Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.1.3 Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.2.3 AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Merck
  11.3.1 Merck Company Information
  11.3.2 Merck Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.3.3 Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Merck Main Business Overview
  11.3.5 Merck Latest Developments
11.4 AbbVie
  11.4.1 AbbVie Company Information
  11.4.2 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.4.3 AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AbbVie Main Business Overview
  11.4.5 AbbVie Latest Developments
11.5 Bausch Health
  11.5.1 Bausch Health Company Information
  11.5.2 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.5.3 Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bausch Health Main Business Overview
  11.5.5 Bausch Health Latest Developments
11.6 GlaxoSmithKline
  11.6.1 GlaxoSmithKline Company Information
  11.6.2 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.6.3 GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 GlaxoSmithKline Main Business Overview
  11.6.5 GlaxoSmithKline Latest Developments
11.7 ReViral
  11.7.1 ReViral Company Information
  11.7.2 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.7.3 ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 ReViral Main Business Overview
  11.7.5 ReViral Latest Developments
11.8 Gilead Sciences
  11.8.1 Gilead Sciences Company Information
  11.8.2 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.8.3 Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Gilead Sciences Main Business Overview
  11.8.5 Gilead Sciences Latest Developments
11.9 Teva Pharmaceutical
  11.9.1 Teva Pharmaceutical Company Information
  11.9.2 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
  11.9.3 Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Teva Pharmaceutical Main Business Overview
  11.9.5 Teva Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Respiratory Syncytial Virus (RSV) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Respiratory Syncytial Virus (RSV) Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Molecular Diagnosis
Table 4. Major Players of Rapid Antigen Testing
Table 5. Major Players of Other
Table 6. Respiratory Syncytial Virus (RSV) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type (2020-2025)
Table 9. Respiratory Syncytial Virus (RSV) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application (2020-2025)
Table 12. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Player (2020-2025)
Table 14. Respiratory Syncytial Virus (RSV) Diagnostics Key Players Head office and Products Offered
Table 15. Respiratory Syncytial Virus (RSV) Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Region (2020-2025)
Table 20. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Country (2020-2025)
Table 24. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type (2020-2025)
Table 26. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application (2020-2025)
Table 28. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Region (2020-2025)
Table 30. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Country (2020-2025)
Table 34. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus (RSV) Diagnostics
Table 40. Key Market Challenges & Risks of Respiratory Syncytial Virus (RSV) Diagnostics
Table 41. Key Industry Trends of Respiratory Syncytial Virus (RSV) Diagnostics
Table 42. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Roche Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 47. Roche Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 48. Roche Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Roche Main Business
Table 50. Roche Latest Developments
Table 51. AstraZeneca Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 52. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 53. AstraZeneca Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Merck Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 57. Merck Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 58. Merck Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Merck Main Business
Table 60. Merck Latest Developments
Table 61. AbbVie Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 62. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 63. AbbVie Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. AbbVie Main Business
Table 65. AbbVie Latest Developments
Table 66. Bausch Health Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 67. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 68. Bausch Health Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Bausch Health Main Business
Table 70. Bausch Health Latest Developments
Table 71. GlaxoSmithKline Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 72. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 73. GlaxoSmithKline Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. GlaxoSmithKline Main Business
Table 75. GlaxoSmithKline Latest Developments
Table 76. ReViral Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 77. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 78. ReViral Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. ReViral Main Business
Table 80. ReViral Latest Developments
Table 81. Gilead Sciences Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 82. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 83. Gilead Sciences Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Gilead Sciences Main Business
Table 85. Gilead Sciences Latest Developments
Table 86. Teva Pharmaceutical Details, Company Type, Respiratory Syncytial Virus (RSV) Diagnostics Area Served and Its Competitors
Table 87. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Product Offered
Table 88. Teva Pharmaceutical Respiratory Syncytial Virus (RSV) Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Teva Pharmaceutical Main Business
Table 90. Teva Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Respiratory Syncytial Virus (RSV) Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Respiratory Syncytial Virus (RSV) Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Respiratory Syncytial Virus (RSV) Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Respiratory Syncytial Virus (RSV) Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type in 2024
Figure 10. Respiratory Syncytial Virus (RSV) Diagnostics in Hospital
Figure 11. Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Hospital (2020-2025) & ($ millions)
Figure 12. Respiratory Syncytial Virus (RSV) Diagnostics in Clinic
Figure 13. Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Clinic (2020-2025) & ($ millions)
Figure 14. Respiratory Syncytial Virus (RSV) Diagnostics in Laborary
Figure 15. Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Laborary (2020-2025) & ($ millions)
Figure 16. Respiratory Syncytial Virus (RSV) Diagnostics in Other
Figure 17. Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Other (2020-2025) & ($ millions)
Figure 18. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application in 2024
Figure 19. Global Respiratory Syncytial Virus (RSV) Diagnostics Revenue Market Share by Player in 2024
Figure 20. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2020-2025 ($ millions)
Figure 25. Americas Respiratory Syncytial Virus (RSV) Diagnostics Value Market Share by Country in 2024
Figure 26. United States Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Region in 2024
Figure 31. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 33. China Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Country in 2024
Figure 40. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. APAC Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. United States Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. China Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. India Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. France Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. UK Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Israel Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)
Figure 78. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market Size 2026-2031 ($ millions)